Moody National Bank Trust Division’s Quest Diagnostics DGX Stock Holding History

Moody National Bank Trust Division’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,481	Closed	-$203K	–	466
2024 Q2	$203K	Sell	1,481 -963	-39%	-$132K	0.02%	432
2024 Q1	$325K	Sell	2,444 -89	-4%	-$11.5K	0.03%	382
2023 Q4	$349K	Sell	2,533 -1,068	-30%	-$140K	0.03%	389
2023 Q3	$439K	Sell	3,601 -183	-5%	-$24.4K	0.03%	419
2023 Q2	$532K	Buy	3,784 +82	+2%	+$11.3K	0.04%	355
2023 Q1	$524K	Hold	3,702	–	–	0.04%	353
2022 Q4	$579K	Sell	3,702 -39	-1%	-$5.6K	0.05%	310
2022 Q3	$459K	Hold	3,741	–	–	0.05%	345
2022 Q2	$498K	Sell	3,741 -4,387	-54%	-$598K	0.05%	286
2022 Q1	$1.11M	Sell	8,128 -468	-5%	-$65.2K	0.03%	204
2021 Q4	$1.49M	Sell	8,596 -3,269	-28%	-$497K	0.04%	175
2021 Q3	$1.72M	Sell	11,865 -17	-0.1%	-$2.49K	0.03%	245
2021 Q2	$1.57M	Sell	11,882 -35	-0.3%	-$4.58K	0.03%	253
2021 Q1	$1.53M	Sell	11,917 -33	-0.3%	-$4.07K	0.04%	248
2020 Q4	$1.42M	Hold	11,950	–	–	0.04%	236
2020 Q3	$1.37M	Hold	11,950	–	–	0.04%	224
2020 Q2	$1.36M	Sell	11,950 -194	-2%	-$20.6K	0.04%	222
2020 Q1	$975K	Hold	12,144	–	–	0.03%	225
2019 Q4	$1.3M	Hold	12,144	–	–	0.03%	223
2019 Q3	$1.3M	Hold	12,144	–	–	0.04%	220
2019 Q2	$1.24M	Hold	12,144	–	–	0.04%	219
2019 Q1	$1.09M	Buy	12,144 +62	+0.5%	+$5.37K	0.03%	231
2018 Q4	$1.01M	Buy	12,082 +182	+2%	+$17.1K	0.03%	227
2018 Q3	$1.28M	Buy	11,900 +9,270	+352%	+$1.02M	0.03%	220
2018 Q2	$289K	Hold	2,630	–	–	0.01%	227
2018 Q1	$264K	Sell	2,630 -100	-4%	-$10.2K	0.01%	229
2017 Q4	$269K	Hold	2,730	–	–	0.01%	233
2017 Q3	$256K	Sell	2,730 -1,125	-29%	-$119K	0.01%	238
2017 Q2	$428K	Hold	3,855	–	–	0.02%	198
2017 Q1	$379K	Hold	3,855	–	–	0.02%	208
2016 Q4	$354K	Hold	3,855	–	–	0.02%	208
2016 Q3	$326K	Hold	3,855	–	–	0.02%	219
2016 Q2	$314K	Hold	3,855	–	–	0.02%	216
2016 Q1	$276K	Hold	3,855	–	–	0.02%	228
2015 Q4	$274K	Hold	3,855	–	–	0.02%	213
2015 Q3	$237K	Hold	3,855	–	–	0.02%	218
2015 Q2	$280K	Hold	3,855	–	–	0.02%	207
2015 Q1	$296K	Hold	3,855	–	–	0.02%	208
2014 Q4	$259K	Sell	3,855 -500	-11%	-$31.6K	0.02%	236
2014 Q3	$265K	Hold	4,355	–	–	0.02%	225
2014 Q2	$256K	Hold	4,355	–	–	0.02%	237
2014 Q1	$252K	Hold	4,355	–	–	0.02%	225
2013 Q4	$233K	Sell	4,355 -15	-0.3%	-$890	0.02%	233
2013 Q3	$270K	Sell	4,370 -175	-4%	-$10.5K	0.02%	214
2013 Q2	$276K	Buy	+4,545	New	+$271K	0.02%	200

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Moody National Bank Trust Division's DGX Position: Q3 2024 in Review

Moody National Bank Trust Division sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 1,481 shares — an estimated $203K sold.

Moody National Bank Trust Division first reported a position in DGX in Q2 2013 and held it in 45 quarters. The position peaked at $1.72M in Q3 2021. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

Moody National Bank Trust Division reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
Moody National Bank Trust Division sold 1,481 Quest Diagnostics shares in Q3 2024, an estimated $203K.
Moody National Bank Trust Division first reported a position in Quest Diagnostics in Q2 2013 and held it in 45 quarters.
Moody National Bank Trust Division's Quest Diagnostics position peaked at $1.72M in Q3 2021.
847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on Moody National Bank Trust Division's 13F filing for Q3 2024, filed 3 Oct 2024.